Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |